Magnus Financial Group’s BioCardia BCDA Stock Holding History

Magnus Financial Group’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	-$60K	–	248
2021 Q2	$60K	Buy	+1,000	New	+$60.7K	0.01%	238

Other funds holding BCDA

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnus Financial Group's BCDA Position: Q3 2021 in Review

Magnus Financial Group sold out of BioCardia (BCDA) in Q3 2021, closing a stake of 1,000 shares — an estimated $60K sold.

Magnus Financial Group first reported a position in BCDA in Q2 2021 and held it in 1 quarter. The position peaked at $60K in Q2 2021. 22 funds tracked by Wall St. Rank hold BCDA as of Q3 2021.

Magnus Financial Group reported no remaining BioCardia position as of Q3 2021 after selling out during the quarter.
Magnus Financial Group sold 1,000 BioCardia shares in Q3 2021, an estimated $60K.
Magnus Financial Group first reported a position in BioCardia in Q2 2021 and held it in 1 quarter.
Magnus Financial Group's BioCardia position peaked at $60K in Q2 2021.
22 funds tracked by Wall St. Rank held BioCardia as of Q3 2021.

Based on Magnus Financial Group's 13F filing for Q3 2021, filed 12 Nov 2021.